Cyclezyme AB (XSAT:CYCLE) Cash-to-Debt : 11.61 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cyclezyme AB Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cyclezyme AB's cash to debt ratio for the quarter that ended in Dec. 2023 was 11.61.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cyclezyme AB could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Cyclezyme AB's Cash-to-Debt or its related term are showing as below:

XSAT:CYCLE' s Cash-to-Debt Range Over the Past 10 Years
Min: 11.61 Med: 5067.82 Max: No Debt
Current: 11.61

During the past 4 years, Cyclezyme AB's highest Cash to Debt Ratio was No Debt. The lowest was 11.61. And the median was 5067.82.

XSAT:CYCLE's Cash-to-Debt is ranked better than
82.71% of 1550 companies
in the Chemicals industry
Industry Median: 0.74 vs XSAT:CYCLE: 11.61

Cyclezyme AB Cash-to-Debt Historical Data

The historical data trend for Cyclezyme AB's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cyclezyme AB Cash-to-Debt Chart

Cyclezyme AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

135.64

11.61

Cyclezyme AB Semi-Annual Data
	Dec20	Dec21	Dec22	Dec23
Cash-to-Debt	No Debt	No Debt	135.64	11.61

Competitive Comparison of Cyclezyme AB's Cash-to-Debt

For the Specialty Chemicals subindustry, Cyclezyme AB's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyclezyme AB's Cash-to-Debt Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Cyclezyme AB's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cyclezyme AB's Cash-to-Debt falls into.

Cyclezyme AB Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cyclezyme AB's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.803	/	(0.042	+	0.458)
	=	11.61

Cyclezyme AB's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.803	/	(0.042	+	0.458)
	=	11.61

Cyclezyme AB (XSAT:CYCLE) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cyclezyme AB Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cyclezyme AB's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclezyme AB (XSAT:CYCLE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cyclezyme AB (XSAT:CYCLE) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.cyclezyme.se

Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.

Cyclezyme AB (XSAT:CYCLE) Headlines

No Headlines